Biochemistry, Genetics and Molecular Biology
Immune Checkpoints
100%
T Cell
90%
CD8
65%
T Cell Receptor
44%
Antigen Specificity
38%
PD-L1
30%
Nonobese Diabetic Mouse
23%
Cell Proliferation
23%
Tumor-Associated Macrophage
23%
Janus Kinase
19%
Bromodomain
19%
Cell Expansion
19%
Autoantigen
19%
Interferon
19%
Tumor-Infiltrating Lymphocytes
19%
Lymphocyte
19%
Cancer Model
19%
RNA Sequence
19%
Tumor Antigen
16%
Interferon Gamma
14%
Immunocompetent Cell
14%
Cytotoxic T Cell
11%
Suppressor of Cytokine Signaling 1
9%
Mouse Mutant
9%
Interleukin 2
9%
Clinical Trial
9%
Peripheral Blood Mononuclear Cell
9%
Transcriptome
9%
Memory B Cell
9%
Immunity
8%
Epigenetics
8%
Dynamics
7%
Flow Cytometry
6%
Cytokine
6%
Fluorouracil
5%
CTLA-4
5%
Immunology and Microbiology
Immunity
61%
Cytotoxic T-Cell
49%
Antigen Specificity
43%
Interferon Type I
39%
Immune Checkpoint Blockade
39%
CD8
34%
T Cell Receptor
29%
RNA Sequence
26%
Cyclophosphamide
19%
Interferon Gamma
19%
Tumor Necrosis Factor Alpha
19%
Cell Expansion
19%
Autoantigen
19%
T-Helper Cell
19%
Nonobese Diabetic Mouse
19%
Lymphocyte
19%
Tumor-Infiltrating Lymphocytes
19%
Metabolite
19%
Programmed Death-Ligand 1
16%
Tumor Antigen
16%
Cytokine Signaling
15%
Immunotherapy
14%
Gene Expression
13%
Interleukin 2
13%
Mouse Mutant
13%
Immunocompetent Cell
11%
T Cell
9%
Transcriptome
9%
Arm
9%
Tumor Cell
9%
Peripheral Blood Mononuclear Cell
9%
Memory B Cell
9%
CTLA-4
7%
Major Histocompatibility Complex
6%
Suppressor Gene
6%
Neutralization
6%
Interferon-Gamma Receptor
6%
Autoimmune Disease
6%
Proinflammatory Cytokine
6%
Receptor Gene
6%
STAT1
6%
Polyinosinic:polycytidylic Acid
6%
Tumor-Associated Macrophage
5%
Medicine and Dentistry
T Cell
33%
Neoplasm
27%
Cytotoxic T-Cell
24%
T Cell Proliferation
23%
Lymphocyte
23%
Diabetes
19%
Cellular Immunity
19%
Adoptive Immunotherapy
19%
Ex Vivo
19%
Melanoma
19%
Tumor Infiltrating Lymphocyte
19%
Antimetabolite
19%
Immune Checkpoint Blockade
19%
Programmed Death-Ligand 1
18%
Cell Therapy
12%
Malignant Pleural Effusion
11%
Immunity
11%
Biological Marker
7%
Tumor Microenvironment
7%
Tumor Model
7%
Proteus Syndrome
6%
CTLA-4
5%